![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Idmos | LSE:IDO | London | Ordinary Share | GB00B035JB54 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:9076F IDMoS plc 18 October 2007 For immediate release 18 October 2007 IDMoS plc Product Launch IDMoS confirms launch of dental product at key industry event IDMoS plc (AIM: IDO) ('IDMoS' or the 'Group'), the specialists in disease detection and monitoring technology, confirms that today it officially launches its CarieScan (previously named Caries Detection Device) and CarieScan Plus (previously named Caries Management Support System) products at this year's British Dental Trade Association meeting at the NEC in Birmingham (18th - 20th October). The Group is also pleased to confirm that it has received its first product order. CarieScan is a caries detection product developed by internationally recognised dental and clinical diagnostics experts Professor Nigel Pitts and Dr Chris Longbottom and is based on AC impedance spectroscopy. It facilitates earlier and more accurate detection of tooth decay than currently possible with any other commercially available system and aims to exploit a global shift towards preventive management of dental decay. Last month Denplan Limited ('Denplan') agreed to promote IDMoS's CarieScan products to their network of 6,500 dental practices, representing over 70% of the UK dental plan market. Graham Lay, Chief Operating Officer of IDMoS plc, said: "We have worked hard to achieve the launch of the CarieScan products into a significant market, and it is gratifying to achieve the first launch of the product with such a strong strategic partner as Denplan. We remain focussed on the remaining significant steps to be taken to achieve full global launch and look forward to working with our partners to achieve this." Dr Roger Matthews, Chief Dental Officer, Denplan, said: "We are extremely impressed with the instruments and the research findings to date and welcome the chance to promote it to our members as a truly innovative aid to early diagnosis and an integral part of preventive practice." For further information please call: IDMoS plc John Pool/Graham Lay 01382 598 440 Chairman/ COO Buchanan Communications 0131 226 4427/07914 437 997 Diane Stewart/Karen Morrison This information is provided by RNS The company news service from the London Stock Exchange END PRLFFUFWWSWSEES
1 Year Idmos Chart |
1 Month Idmos Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions